<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90777">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01979653</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0615</org_study_id>
    <nct_id>NCT01979653</nct_id>
  </id_info>
  <brief_title>A Comparision of Midazolam-dexmedetomidine With Dexmedetomidine Alone for Hemodynamic Stability and Quality of Sedation in Elderly Patients Under Spinal Anesthesia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare midazolam-dexmedetomidine with dexmedetomidine alone
      for hemodynamic stability and quality of sedation in elderly patients under spinal
      anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>hemodynamic stability</measure>
    <time_frame>4 hour</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>comparison of bradycardia incidence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modified Observer Assessment of Alertness/Sedation (MOAAS) scale</measure>
    <time_frame>4 hour</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Sedation; Aged; Hemodynamics</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexmedetomidine 0.5 mcg/kg for 10 min + normal saline (volume-matched) bolus + dexmedetomidine 0.2-0.4 mcg/kg/hr infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine + midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>normal saline (volume-matched) for 10 min + midazolam 0.2 mg/kg bolus + dexmedetomidine 0.2-0.4 mcg/kg/hr infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine alone or dexmedetomidine + midazolam</intervention_name>
    <arm_group_label>dexmedetomidine alone</arm_group_label>
    <arm_group_label>dexmedetomidine + midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged â‰¥ 65 years

          -  ASA physical status class I-II

          -  the patients who want sedation during elective lower limb surgery under spinal
             anesthesia

        Exclusion Criteria:

          -  contraindication to spinal anesthesia

          -  neurologic or cognitive dysfunction

          -  severe cardiovascular or pulmonary disease

          -  refusal to participation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>So Yeon Kim, MD, PhD</last_name>
    <phone>82-2-2227-4470</phone>
    <email>KIMSY326@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>So Yeon Kim, MD, PhD</last_name>
      <phone>82-2-2227-4470</phone>
      <email>KIMSY326@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 3, 2013</lastchanged_date>
  <firstreceived_date>November 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>So Yeon Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
